New cancer clinical trial: Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer

Published on: April 20, 2018 at 12:00PM
Condition:   Endometrial Cancer
Interventions:   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Avelumab
Sponsor:   National Cancer Institute, Naples
Not yet recruiting
https://ift.tt/2HeqvjE